Severe and prolonged lymphopenia observed in patients treated with bendamustine and erlotinib for metastatic triple negative breast cancer
Rachel M. Layman(The University of Texas MD Anderson Cancer Center), Charles L. Shapiro(Tisch Hospital), Ewa Mrózek(The Ohio State University Comprehensive Cancer Center – Arthur G. James Cancer Hospital and Richard J. Solove Research Institute), Bhuvaneswari Ramaswamy(The Ohio State University), Raquel E. Reinbolt(The Ohio State University), M J Lynn(Nationwide Children's Hospital), Sarah Carothers(The Ohio State University Comprehensive Cancer Center – Arthur G. James Cancer Hospital and Richard J. Solove Research Institute), Susan Ottman(The Ohio State University), Maryam B. Lustberg(Yale Cancer Center), Eric H. Kraut(The Ohio State University), Anissa Bingman(The Ohio State University), Amy S. Ruppert(The University of Texas MD Anderson Cancer Center), Robert Wesolowski(The Ohio State University Wexner Medical Center)
Cited by 47
Related Papers
Prevention and Management of Chemotherapy-Induced Peripheral Neuropathy in Survivors of Adult Cancers: American Society of Clinical Oncology Clinical Practice Guideline
|Journal of Clinical Oncology|2014|1.2k
Prevention and Management of Chemotherapy-Induced Peripheral Neuropathy in Survivors of Adult Cancers: ASCO Guideline Update
|Journal of Clinical Oncology|2020|1.1k
International prognostic indices in diffuse large B-cell lymphoma: a comparison of IPI, R-IPI, and NCCN-IPI
|Blood|2020|372